World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
30990
World Ranking
15936
National Ranking
836

Raymonde Busch publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raymonde Busch sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 293 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raymonde Busch D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raymonde Busch sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raymonde Busch is a researcher affiliated with the Technical University of Munich in Germany. Their work spans multiple interdisciplinary fields, with a focus on surfaces, coatings and films, electrical and electronic engineering, molecular biology, immunology, and structural biology.

The scientist's research addresses several specific topics, including:

  • Electron and X-Ray Spectroscopy Techniques
  • Advanced Electron Microscopy Techniques and Applications
  • T-cell and B-cell Immunology
  • RNA Research and Splicing
  • Advancements in Photolithography Techniques
  • Immune Cell Function and Interaction
  • Diabetes and associated disorders

Raymonde Busch has collaborated frequently with other researchers in the field. Notable co-authors include Jian-Min Zuo (8 publications), Saran Pidaparthy (5 publications), Derek C. Macallan (4 publications), Becca Asquith (4 publications), and Haoyang Ni (4 publications).

Their recent academic publications are as follows:

  • "KIR-HLA interactions extend human CD8+ T cell lifespan in vivo," 2023, Journal of Clinical Investigation
  • "Near-infrared ultrafast third-order nonlinear optical response of 2D NbS2, NbSe2, ZrTe2, and MoS2," 2023, Optics Letters
  • "Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD," 2020, UNC Libraries
  • "Atomic Resolution Tomography on Simulated Amorphous Silicon Nanoparticles," 2023, Microscopy and Microanalysis
  • "Combined 4D-STEM and EELS for Mapping Chemical-structural Heterogeneity in Cathode Materials," 2023, Microscopy and Microanalysis

The scientist has multiple publications in prominent venues. The most frequent publication venues include:

  • Microscopy and Microanalysis (7 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (2 publications)
  • Acta Crystallographica Section A Foundations and Advances (2 publications)
  • Journal of Clinical Investigation (1 publication)
  • Optics Letters (1 publication)

In addition to peer-reviewed journal articles, Raymonde Busch has contributed to book publications. One example is the 2023 book titled Behind a great medical drug there is always a great scientist!, published by Frontiers Media.

Best Publications

  • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

    Michael Hallek;K. Fischer;Gunter Fingerle-Rowson;A.M. Fink

  • Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

    Valentin Goede;Kirsten Fischer;Raymonde Busch;Anja Engelke

  • Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

    Karen Becker;James D. Mueller;Christoph Schulmacher;Katja Ott

  • Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.

    Barbara F. Eichhorst;Raymonde Busch;Georg Hopfinger;Rita Pasold

  • Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging

    Wolfgang A. Weber;Katja Ott;Karen Becker;Hans-Joachim Dittler

  • Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer.

    Erika Rosivatz;Ingrid Becker;Katja Specht;Elena Fricke

  • TP53 Mutation and Survival in Chronic Lymphocytic Leukemia

    Thorsten Zenz;Barbara Eichhorst;Raymonde Busch;Tina Denzel

  • First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.

    Barbara Eichhorst;Anna-Maria Fink;Jasmin Bahlo;Raymonde Busch

  • Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group.

    Siewert;Böttcher K;Roder Jd;Busch R

  • Gene mutations and treatment outcome in chronic lymphocytic leukemia: Results from the CLL8 trial

    Stephan Stilgenbauer;Andrea Schnaiter;Peter Paschka;Thorsten Zenz;Thorsten Zenz

  • Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial.

    Sebastian Böttcher;Matthias Ritgen;Kirsten Fischer;Stephan Stilgenbauer

  • Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

    Kirsten Fischer;Paula Cramer;Raymonde Busch;Sebastian Böttcher

  • Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

    Katja Ott;Wolfgang A. Weber;Florian Lordick;Karen Becker

  • Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

    Kirsten Fischer;Paula Cramer;Raymonde Busch;Stephan Stilgenbauer

  • Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992

    Jürgen D. Roder;Knut Böttcher;J. Rüdiger Siewert;Raymonde Busch

  • First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia

    Barbara F. Eichhorst;Raymonde Busch;Stephan Stilgenbauer;Martina Stauch

  • Prognostic relevance of systematic lymph node dissection in gastric carcinoma

    D. H. Roukos;G. Baltogiannis;D. Cassioumis;J. R. Siewert

  • Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.

    Katja Ott;Ulrich Fink;Karen Becker;Alexander Stahl

  • Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

    Peter Dreger;Hartmut Döhner;Matthias Ritgen;Sebastian Böttcher

  • Shared decision making for in-patients with schizophrenia.

    J. Hamann;B. Langer;V. Winkler;R. Busch

Frequent Co-Authors

Michael Hallek
Michael Hallek University of Cologne
Stephan Stilgenbauer
Stephan Stilgenbauer University of Ulm
Hartmut Döhner
Hartmut Döhner University of Ulm
Michael Kneba
Michael Kneba Kiel University
Heinz Höfler
Heinz Höfler Technical University of Munich
J. R. Siewert
J. R. Siewert University of Freiburg
John Hess
John Hess Ludwig-Maximilians-Universität München
Florian Lordick
Florian Lordick Leipzig University
Ulrich Jäger
Ulrich Jäger Medical University of Vienna
Stefan Leucht
Stefan Leucht Technical University of Munich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA doesn’t always mean following the traditional path to become a doctor. Many rewarding healthcare professions are accessible through flexible online degree programs, allowing you to balance studies with other commitments.

For those interested in patient care, nursing remains a popular option. If you are wondering what is the easiest nursing program to get into, there are schools designed to provide more accessible entry points into the nursing field. Some programs even waive standardized testing; in fact, you can find do you have to take the teas test to get into nursing school to see which schools offer this pathway.

For those drawn to healthcare but not direct patient care, medical billing and coding is a fast-growing sector offering fulfilling opportunities. You can explore medical billing and coding schools online with financial aid—a great option for working adults seeking a flexible, in-demand credential.

Alternatively, if you envision yourself in leadership, pursuing a healthcare administration degree online can open doors to management roles in hospitals, clinics, and health organizations.

Best Scientists Citing Raymonde Busch

Trending Scientists

Recently Published Articles